INTERNATIONAL PATENT: VERTEX PHARMACEUTICALS INCORPORATED FILES APPLICATION FOR "MUCIN-5B (MUC5B) TARGETED SIRNA AND ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF"

GENEVA, Oct. 1 -- VERTEX PHARMACEUTICALS INCORPORATED (50 Northern AvenueBoston, Massachusetts 02210) filed a patent application (PCT/US2025/020557) for "MUCIN-5B (MUC5B) TARGETED SIRNA AND ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF" on Mar 19, 2025. With publication no. WO/2025/199231, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): D'ASTOLFO, Diego (Vertex Pharmaceuticals Incorporated50 Northern AvenueBoston, Massachusetts 02210)

Abstract: Disclosed herein are double stranded ribonucleic acids (dsRNAs) and s...